— Know what they know.
Not Investment Advice

PRFX NASDAQ

PRF Technologies Ltd.
1W: -5.8% 1M: -5.6% 3M: -33.8% YTD: -73.6% 1Y: -33.3% 3Y: -98.9% 5Y: -99.9%
$0.92
-0.03 (-3.19%)
 
Weekly Expected Move ±9.7%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 36 · $74089 mcap · 76849 float · 2435.20% daily turnover · Short 25% of daily vol

Income Trends

Revenue
$17K +0.0% ▲
Gross Profit
-$827K -5068.8% ▼
Operating Income
-$5M +66.0% ▲
Net Income
-$5M +66.8% ▲
EPS (Diluted)
$-7.47 +99.1% ▲
EBITDA
-$4M +71.0% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$0$86K$0$0$17K
YoY Growth+0.0%+0.0%-100.0%+0.0%+0.0%
Cost of Revenue$7K$15K$15K$16K$844K
Gross Profit-$7K$71K-$15K-$16K-$827K
Gross Margin—82.6%——-4864.7%
R&D Expenses$3M$4M$6M$12M$1M
SG&A Expenses$4M$4M$4M$3M$3M
Operating Expenses$7M$9M$10M$15M$4M
Operating Income-$7M-$9M-$10M-$15M-$5M
Operating Margin—-10312.8%——-29335.3%
Interest Expense$10K$61K$384K$14K$10K
Income Before Tax-$7M-$9M-$9M-$15M-$5M
Tax Expense$6K$9K$8K$8K$8K
Net Income-$7M-$9M-$9M-$15M-$5M
Net Margin—-10223.3%——-28458.8%
EPS (Diluted)$-177.23$-197.92$-171.33$-32.16$-7.47
EBITDA-$7M-$9M-$10M-$15M-$4M
Shares Outstanding408844442154538453544647973

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms